JonathanWoodcockMD

Neurophysiology, Neurorehabilitation, Dementia & Geriatrics

"Assistant Professor Clinical Director, Memory Disorders Clinic Clinical Director, Rocky Mountain Alzheimer’s Disease Center University of Colorado School of Medicine"

Join to view full profile

Dr. Woodcock is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Woodcock's full profile

Already have an account?

Office
3055 North Roslyn St.
Suite 120
Denver, CO 80238
Phone+1 720-848-2080

Fax+1 720-848-2106

Education & Training

Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1982 - 1984
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1979 - 1982
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1977 - 1979
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1977
Houghton CollegeBA, Chemistry, 1969 - 1973

Certifications & Licensure

CO State Medical License 1989 - 2025
FL State Medical License 2021 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Psychiatry
United Council for Neurologic SubspecialitesBehavioral Neurology and Neuropsychiatry

Clinical Trials

Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease Start of enrollment: 2011 Mar 01
Completed
Phase 2

Publications & Presentations

PubMed

Psychiatric Screening Measures in Behavioral Variant Frontotemporal Dementia.
Peter S Pressman, Joie Molden, Hal S Wortzel, Evan Plys, Jonathan H Woodcock
The Journal of Neuropsychiatry and Clinical Neurosciences. 2024-01-01
Use of coffee grounds to test olfaction for predicting cognitive dysfunction and decline.
Alexander J. Rajic, Peter Pressman, Jonathan H. Woodcock, Heidi J. Chial, Christopher M. Filley
Journal of the Neurological Sciences. 2021-05-31
44 citations
Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer's disease.
Huntington Potter, Jonathan H. Woodcock, Timothy Boyd, Christina M. Coughlan, John R. O'Shaughnessy
Alzheimer's & Dementia. 2021-01-01

Press Mentions

St. Anselm College Installs Ionizing Devices to Battle COVID-19July 7th, 2020
Vitamin B12 Deficiency Symptoms: How to Tell if You Are Lacking the VitaminJune 6th, 2019
FREE: Denver Post Hosts Understanding Alzheimer’s Event Feb. 7February 7th, 2019
Join now to see all